Candel Therapeutics Inc
Veridion Score
Composite trend over time
Why is CADL moving today?
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CADL.
CADL insider activity
Candel Therapeutics Inc
3 insiders bought in the last 90 days
Net buying: $3.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | 2026-03-31 | Loggia Nicoletta | Insider | buy | $4.11 | 779 | 779 | $3K | SEC Form 4 |
| 2026-04-02 | 2026-03-31 | Manning Paul B | Insider | buy | $4.11 | 4,618 | 4,618 | $19K | SEC Form 4 |
| 2026-04-02 | 2026-03-31 | PAPA JOSEPH C | Insider | buy | $4.11 | 2,795 | 2,795 | $11K | SEC Form 4 |
| 2026-02-26 | 2026-02-23 | Manning Paul B | Insider | buy | $5.45 | 550,458 | 2,763,527 | $3.0M | SEC Form 4 |
| 2025-07-30 | 2025-07-28 | Nichols William Garrett | Insider | sell | $6.98 | 937 | 52,493 | $7K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCADL contract awards, year to date.
Public federal awards linked to this ticker.
CADL lobbying filings, year to date.
Registered lobbying filings matched to Candel Therapeutics Inc.